Maternal bleeding complications in pregnancies affected by red blood cell alloimmunization. (April 2022)

• Record Type: Journal Article
• Authors: Beitl, Klara; Holzer, Iris; Körmöczi, Günther F.; Hein, Antonia Valentina; Förster, Judit; Seemann, Rudolf; Ott, Johannes; Ulm, Barbara
• Is Part Of: European journal of obstetrics, gynecology, and reproductive biology. Volume 271(2022)
• Page Start: 271
• Page End: 277
• Publication Date: 2022-04
• Subjects: Red blood cell alloimmunization -- Maternal hemorrhage -- Bleeding complication -- Postpartum bleeding; Obstetrics -- Periodicals; Gynecology -- Periodicals; Reproductive health -- Periodicals; Gynecology -- Periodicals; Obstetrics -- Periodicals; Reproduction -- Periodicals; Obstétrique -- Périodiques; Gynécologie -- Périodiques; Reproduction -- Périodiques; Verloskunde; Gynaecologie; Voortplanting (biologie); Gynecology; Obstetrics; Reproduction; Electronic journals; Periodicals; Electronic journals; 618.05
• DOI: 10.1016/j.ejogrb.2022.02.178
• Languages: English
• ISSNs: 0301-2115

Abstract

Abstract: Objective: To investigate whether women with red blood cell (RBC) 1 alloimmunization are more likely to experience bleeding complications during pregnancy or delivery than women without RBC alloimmunization. Study design: Retrospective study involving all singleton pregnancies affected by RBC alloimmunization and without pre-existing maternal bleeding disorders or placenta previa, from 1 July 1999 to 30 June 2019 ("cases"). Only bleedings not related to invasive procedures (amnio- or cordocenteses) were included. Patients who were already at increased risk of pre- or perinatal bleeding due to their medical history (pre-existing bleeding disorders, antithrombotic therapy), or known obstetrics parameters (placental abnormalities etc.) were not included a priori. Cases were compared to controls without RBC alloimmunization, matched for maternal age and body mass index, from the same tertiary referral center in Austria. Results: 130 cases were compared to 130 controls. Cases had significantly more previous pregnancies and miscarriages and their newborns had lower birthweight and were more often transferred to the intensive care unit than newborns of controls. 18/130 (13.8%) cases, compared to 8/130 (6.2%) controls experienced any bleeding during pregnancy or delivery (p = 0.061). Bleeding most often happened during the third trimester (cases: 4.6% vs. controls 0.8%, p = 0.12) and during or after delivery (cases: 7.7% vs. controls: 4.6%, p = 0.168). Binary logistic regression for the prediction of any bleeding complication during pregnancy, delivery or postpartum revealed immunization against RBC antigens as the only independent contributor (p = 0.04). Age, smoking, or previous obstetric history had no influence on the likelihood of maternal bleeding complications. Neither RBC antibody specificity nor titers were predictive of maternal bleeding during pregnancy or delivery. Conclusion: Pregnancies affected by RBC alloimmunization might be at increased risk of maternal bleeding complications during pregnancy and delivery.